Treatment of multiple warts in a renal transplant recipient with decreased laser doses after application of a light absorbing dye.
OBJECTIVE
Multiple warts are a tremendous problem in immunosuppressed patients. Standard treatment has low efficacy and is often painful. We examined a new treatment combination of gentian violet and dye-laser.


METHODS
A 55-year-old male renal transplant recipient was treated with dye-laser at 585 nm after application of gentian violet 0.5%.


RESULTS
One laser pulse made the stain explode and evaporate and resulted in a considerable reduction in warts size with minimal pain and tissue damage.


CONCLUSIONS
Application of gentian violet before dye-laser treatment may be effective in the battle against warts in immunocompromised patients.
Faurschou
Annesofie
A
Department of Dermatology, Bispebjerg Hospital, Copenhagen NV, Denmark. AF16@bbh.hosp.dk
Wulf
Hans Christian
HC
D000279:Administration, Cutaneous; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D005840:Gentian Violet / Q000008:administration & dosage*; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation; D028022:Low-Level Light Therapy; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D014860:Warts / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*
D000891:Anti-Infective Agents, Local; D005840:Gentian Violet